Drug Prices Are a Populist Campaign Issue. Here Are the Latest Proposals to Lower Costs.

After years of public outrage, some bipartisan solutions are emerging. But whether they will make it through a divided Washington is still unclear. KATIE THOMAS https://nyti.ms/2Zu2fyQ http://bit.ly/2WSgWyY The New York Times Health your-feed-science, Drugs (Pharmaceuticals), United States Politics and Government, Health Insurance and Managed Care, Prices (Fares, Fees and Rates) June 16, 2019 at 02:00AM